Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Market Cap	1.08B -32.3%
Revenue (ttm)	34.45M +390.9%
Net Income	-18.92M
EPS	-0.16
Shares Out	119.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	324,201
Average Volume	586,278
Open	n/a
Previous Close	8.90
Day's Range	8.90 - 9.10
52-Week Range	7.10 - 12.70
Beta	0.32
RSI	50.06
Earnings Date	Apr 29, 2026

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablets, capsules, liquids, and ointment. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective vitamins & minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, anti-diabetic oral rehydration salt, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAID; and skin diseases, such as fungal and...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 74
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: CENTRALPHL

Financial Performance

In fiscal year 2025, Central Pharmaceuticals's revenue was 33.06 million, an increase of 11.68% compared to the previous year's 29.60 million. Losses were -21.98 million, -48.18% less than in 2024.